P265 Current UK wide use of the BASMI outcome measure in axial spondyloarthritis: an AStretch survey

Abstract Background/Aims The Bath Ankylosing Spondylitis Metrology Index (BASMI) is used in the monitoring of those living with axial spondyloarthritis (axSpA); it is the recommended and validated measure of movement in this patient group. As a physical outcome measure its use has been challenging during the COVID-19 pandemic. The aim of this project is to assess the current application of the BASMI in axSpA services across the UK. Methods A survey was devised to explore when the BASMI is used, by whom and the reasons for its use. The AStretch committee reviewed and re-drafted the questions. The survey was shared across multiple platforms and email professional distribution lists, and was open 2nd-12th October 2021. Results 74 UK healthcare professionals completed the survey. It is mostly physiotherapists who undertake the BASMI (69%); some other clinicians also measure: nurses (10%), medics (9%), physiotherapy support workers (10%), healthcare support workers (2%). Confidence in performing the BASMI averaged at 3.5/5. The majority of respondents record the BASMI in the electronic record (73%); app-based solutions are developing (7%) and paper-only recording diminishing (20%). When asked about frequency, most respondents (73%) recorded “it depends”, implying that the BASMI is used on an individual patient basis. Table 1 presents data with regards to why the BASMI is undertaken, scored by participant ranking, and free text responses about reasons for use. P265 Table 1: Participant ranking score summation for “reason to use the BASMI” and free text “reasons for use of the BASMI” Item Overall Rank Total Score * For all newly diagnosed patients 1 555 To help us devise a bespoke exercise plan 2 513 To address poor movement or function 3 498 To address/encourage adherence to exercise/advice 4 451 It’s part of their on-going management 5 391 Delay to diagnosis affecting start of treatment and therefore movement restrictions apparent 6 356 Guidelines suggest yearly monitoring 7 332 As an outcome measure pre- and post-hydrotherapy 8 295 To address an increase in pain levels 9 277 For patient preference 10 265 Rheumatology team asked for it 11 202 For research purposes/as a part of a clinical trial 12 155 *Score is a weighted calculation. Items ranked first are valued higher than the following ranks, the score is a sum of all weighted rank counts. FREE TEXT REASONS FOR THE USE OF THE BASMI Helpful to patients to objectively understand their movement. Newly diagnosed